Treatment modalities for acne L Fox, C Csongradi, M Aucamp, J Du Plessis, M Gerber Molecules 21 (8), 1063, 2016 | 373 | 2016 |
Review of natural compounds for potential skin cancer treatment TN Chinembiri, LH Du Plessis, M Gerber, JH Hamman, J Du Plessis Molecules 19 (8), 11679-11721, 2014 | 299 | 2014 |
Formulation effects of topical emulsions on transdermal and dermal delivery A Otto, J Du Plessis, JW Wiechers International journal of cosmetic science 31 (1), 1-19, 2009 | 265 | 2009 |
The influence of particle size of liposomes on the deposition of drug into skin J du Plessis, C Ramachandran, N Weiner, DG Müller International journal of pharmaceutics 103 (3), 277-282, 1994 | 246 | 1994 |
Cutaneous tuberculosis overview and current treatment regimens L Van Zyl, J Du Plessis, J Viljoen Tuberculosis 95 (6), 629-638, 2015 | 245 | 2015 |
Transdermal drug delivery enhancement by compounds of natural origin LT Fox, M Gerber, JD Plessis, JH Hamman Molecules 16 (12), 10507-10540, 2011 | 231 | 2011 |
The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAID’s on their transdermal absorption E Beetge, J du Plessis, DG Müller, C Goosen, FJ van Rensburg International journal of Pharmaceutics 193 (2), 261-264, 2000 | 213 | 2000 |
Sinigrin and its therapeutic benefits A Mazumder, A Dwivedi, J Du Plessis Molecules 21 (4), 416, 2016 | 174 | 2016 |
The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage J Du Plessis, C Ramachandran, N Weiner, DG Müller International journal of pharmaceutics 127 (2), 273-278, 1996 | 168 | 1996 |
The selection of non-steroidal anti-inflammatory agents for dermal delivery J Hadgraft, J du Plessis, C Goosen International journal of pharmaceutics 207 (1-2), 31-37, 2000 | 143 | 2000 |
In vitro wound healing and cytotoxic effects of sinigrin–phytosome complex A Mazumder, A Dwivedi, JL Du Preez, J Du Plessis International journal of pharmaceutics 498 (1-2), 283-293, 2016 | 129 | 2016 |
In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells A Dwivedi, A Mazumder, L Du Plessis, JL Du Preez, RK Haynes, ... Nanomedicine: Nanotechnology, Biology and Medicine 11 (8), 2041-2050, 2015 | 109 | 2015 |
Breaching the skin barrier through temperature modulations Y Shahzad, R Louw, M Gerber, J Du Plessis Journal of Controlled Release 202, 1-13, 2015 | 98 | 2015 |
In vitro wound healing and cytotoxic activity of the gel and whole-leaf materials from selected aloe species LT Fox, A Mazumder, A Dwivedi, M Gerber, J Du Plessis, JH Hamman Journal of ethnopharmacology 200, 1-7, 2017 | 96 | 2017 |
An investigation into the biological activity of the selected histidine‐containing diketopiperazines cyclo (His‐Phe) and cyclo (His‐Tyr) K McCleland, PJ Milne, FR Lucieto, C Frost, SC Brauns, M Van De Venter, ... Journal of pharmacy and pharmacology 56 (9), 1143-1153, 2004 | 95 | 2004 |
Topical delivery of liposomally encapsulated gamma-interferon J du Plessis, K Egbaria, C Ramachandran, N Weiner Antiviral research 18 (3-4), 259-265, 1992 | 89 | 1992 |
A comparative study of an in situ adapted diffusion cell and an in vitro Franz diffusion cell method for transdermal absorption of doxylamine JP Venter, DG Müller, J du Plessis, C Goosen European journal of pharmaceutical sciences 13 (2), 169-177, 2001 | 67 | 2001 |
A versatile energy management system for large integrated cooling systems GE Du Plessis, L Liebenberg, EH Mathews, JN Du Plessis Energy conversion and management 66, 312-325, 2013 | 65 | 2013 |
Penetration enhancing effects of selected natural oils utilized in topical dosage forms JM Viljoen, A Cowley, J Du Preez, M Gerber, J Du Plessis Drug development and industrial pharmacy 41 (12), 2045-2054, 2015 | 64 | 2015 |
Correlation between physicochemical characteristics, pharmacokinetic properties and transdermal absorption of NSAID's C Goosen, J Du Plessis, DG Müller, LFJ Van Rensburg International journal of pharmaceutics 163 (1-2), 203-209, 1998 | 63 | 1998 |